A Randomised, Double-blind, Placebo-controlled Study
  • Description A forum to discuss or ask questions about a Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of the H3 Receptor Antagonist, GSK239512 in Subjects with Mild to Moderate Alzheimer's Disease.
  • Threads 1 Discussion
Frequently Asked